THE neuroprotective effects of the NMDA receptor blocker APV were comp
ared with those of bcl-2 in a glutamate-induced excitotoxic cell death
model in cultured rat cortical neurons. Exposure to 100 mu M glutamat
e for 5 h caused similar to 95% of the cultured neurons to die in 24 h
. The NMDA-selective antagonist D-(-)-2-amino-5-phosphonopentanoate (A
PV) protected the neurons effectively when applied prior to or soon af
ter glutamate treatment. However, infection with a viral vector expres
sing the proto-oncogene bcl-2 strongly protected neurons even if appli
ed as late as 8 h following the glutamate insult. These data provides
evidence that APV blocks an early stage of the death cascade in respon
se to elevations of glutamate. By contrast bcl-2 appears to act at a f
airly late stage in the cell death process and these results suggest a
possible clinical role in treatment of ischemic brain disorders.